LIMK1 and hepatocellular carcinoma: During the development of hepatocellular carcinoma, circulating H19 promotes proliferation, migration and invasion and inhibits apoptosis in isoproterenol-treated hepatocellular carcinoma cells by sponging miR-520a-3p upregulating LIMK1 (61).